Dose-reduced [18F]PSMA-1007 PET is feasible for functional imaging of the renal cortex

to related objects

Location
Deutsche Nationalbibliothek Frankfurt am Main
ISSN
2197-7364
Extent
Online-Ressource
Language
Englisch
Notes
online resource.

Bibliographic citation
Dose-reduced [18F]PSMA-1007 PET is feasible for functional imaging of the renal cortex ; volume:8 ; number:1 ; day:29 ; month:10 ; year:2021 ; pages:1-11 ; date:12.2021
EJNMMI Physics ; 8, Heft 1 (29.10.2021), 1-11, 12.2021

Creator
Valind, Kristian
Jögi, Jonas
Minarik, David
Brolin, Gustav
Trägårdh, Elin
Contributor
SpringerLink (Online service)

DOI
10.1186/s40658-021-00419-x
URN
urn:nbn:de:101:1-2022010821013602888377
Rights
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
Last update
15.08.2025, 7:27 AM CEST

Data provider

This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Show original at data provider

Associated

  • Valind, Kristian
  • Jögi, Jonas
  • Minarik, David
  • Brolin, Gustav
  • Trägårdh, Elin
  • SpringerLink (Online service)

Other Objects (12)

Preclinical comparative study of [18F]AlF-PSMA-11 and [18F]PSMA-1007 in varying PSMA expressing tumors

Preclinical comparative study of [18F]AlF-PSMA-11 and [18F]PSMA-1007 in varying PSMA expressing tumors

Multiparametric dynamic whole-body PSMA PET/CT using [68Ga]Ga-PSMA-11 and [18F]PSMA-1007

Multiparametric dynamic whole-body PSMA PET/CT using [68Ga]Ga-PSMA-11 and [18F]PSMA-1007

[18F]PSMA-1007 PET for biochemical recurrence of prostate cancer, a comparison with [18F]Fluciclovine

[18F]PSMA-1007 PET for biochemical recurrence of prostate cancer, a comparison with [18F]Fluciclovine

A Robust [18F]-PSMA-1007 Radiomics Ensemble Model for Prostate Cancer Risk Stratification

A Robust [18F]-PSMA-1007 Radiomics Ensemble Model for Prostate Cancer Risk Stratification

On site production of [18F]PSMA-1007 using different [18F]fluoride activities: practical, technical and economical impact

On site production of [18F]PSMA-1007 using different [18F]fluoride activities: practical, technical and economical impact

18F-Labelled PSMA-1007 shows similarity in structure, biodistribution and tumour uptake to the theragnostic compound PSMA-617

18F-Labelled PSMA-1007 shows similarity in structure, biodistribution and tumour uptake to the theragnostic compound PSMA-617

Heterogeneous uptake of 18F-FDG and 18F-PSMA-1007 PET/CT in lung cancer and lymph node metastasis

Heterogeneous uptake of 18F-FDG and 18F-PSMA-1007 PET/CT in lung cancer and lymph node metastasis

PSMA-Liganden PET/CT bei Patienten mit biochemischem Rezidiv nach radikaler Prostatektomie: Matched-Pair Vergleich von 68Ga-PSMA-11 und 18F-PSMA-1007

PSMA-Liganden PET/CT bei Patienten mit biochemischem Rezidiv nach radikaler Prostatektomie: Matched-Pair Vergleich von 68Ga-PSMA-11 und 18F-PSMA-1007

Diagnostic accuracy of [18F]PSMA-1007 PET/CT in biochemical recurrence of prostate cancer

Diagnostic accuracy of [18F]PSMA-1007 PET/CT in biochemical recurrence of prostate cancer

Gross tumor volume delineation in primary prostate cancer on 18F-PSMA-1007 PET/MRI and 68Ga-PSMA-11 PET/MRI

Gross tumor volume delineation in primary prostate cancer on 18F-PSMA-1007 PET/MRI and 68Ga-PSMA-11 PET/MRI

Optimization of [18F]PSMA-1007 PET-CT using regularized reconstruction in patients with prostate cancer

Optimization of [18F]PSMA-1007 PET-CT using regularized reconstruction in patients with prostate cancer

Diagnostic performance of 18F-PSMA-1007 PET/CT in patients with biochemical recurrent prostate cancer

Diagnostic performance of 18F-PSMA-1007 PET/CT in patients with biochemical recurrent prostate cancer

Related objects